儿童听力损失综合基因面板检测:诊断率影响因素分析
该回顾性队列研究纳入474例儿童期起病听力损失先证者,评估综合基因面板检测(CGPT)诊断率的影响因素。总体诊断率为44%(209/474),涉及41个基因;先天性、双侧、重度听力损失者诊断率较高,而单侧、非先天性、轻度听力损失及耳蜗神经缺陷、早产、NICU入住、特定 ancestry、发育迟缓者诊断率较低。对49例初始CGPT结果不确定者随访,39例(80%)诊断状态改变;128例未诊断者行外显子组测序,8例发现诊断性变异。
要点
- CGPT在儿童听力损失中总体诊断率为44%,先天性、双侧、重度者诊断率更高。
- 单侧、非先天性、轻度听力损失及耳蜗神经缺陷、早产、NICU入住、发育迟缓者诊断率较低。
- CGPT未诊断者可受益于随访研究或扩展检测如外显子组测序。
核心结论
- CGPT能有效识别儿童听力损失的遗传病因,但诊断率受临床特征影响。
- CGPT未诊断的先证者可能受益于随访研究或扩展检测。
研究设计与样本
- 回顾性队列研究,纳入474例2016至2020年在单中心接受CGPT的儿童期起病听力损失先证者。
主要发现
- 总体诊断率为44%(209/474), causative变异涉及41个基因。
- 先天性、双侧、重度听力损失先证者诊断率高,而单侧、非先天性、轻度听力损失、耳蜗神经缺陷、早产、NICU入住、特定ancestry及发育迟缓者诊断率低。
- 49例初始CGPT结果不确定者中,39例(80%)随访后诊断状态变为可能阳性或阴性。
- 128例CGPT未诊断者行外显子组测序,8例发现诊断性发现,其中5例有发育迟缓。
- 剩余255例未诊断,其中173例(173/255)仅有单个变异在常染色体隐性听力损失相关基因,48例(28%,48/173)有匹配表型。
临床怎么用
- 对先天性、双侧、重度听力损失儿童,CGPT诊断率较高,可优先考虑。
- 对单侧、非先天性、轻度听力损失或伴耳蜗神经缺陷、早产、NICU入住、发育迟缓者,应知晓CGPT诊断率较低。
- CGPT结果不确定或未诊断时,可考虑随访研究或外显子组测序等扩展检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate factors influencing the diagnostic yield of comprehensive gene panel testing (CGPT) for hearing loss (HL) in children and to understand the characteristics of undiagnosed probands. STUDY DESIGN: This was a retrospective cohort study of 474 probands with childhood-onset HL who underwent CGPT between 2016 and 2020 at a single center. Main outcomes and measures included the association between clinical variables and diagnostic yield and the genetic and clinical characteristics of undiagnosed probands. RESULTS: The overall diagnostic yield was 44% (209/474) with causative variants involving 41 genes. While the diagnostic yield was high in the probands with congenital, bilateral, and severe HL, it was low in those with unilateral, noncongenital, or mild HL; cochlear nerve deficiency; preterm birth; neonatal intensive care unit admittance; certain ancestry; and developmental delay. Follow-up studies on 49 probands with initially inconclusive CGPT results changed the diagnostic status to likely positive or negative outcomes in 39 of them (80%). Reflex to exome sequencing on 128 undiagnosed probands by CGPT revealed diagnostic findings in 8 individuals, 5 of whom had developmental delays. The remaining 255 probands were undiagnosed, with 173 (173/255) having only a single variant in the gene(s) associated with autosomal recessive HL and 28% (48/173) having a matched phenotype. CONCLUSION: CGPT efficiently identifies the genetic etiologies of HL in children. CGPT-undiagnosed probands may benefit from follow-up studies or expanded testing.
引用
- Yamamoto N, Balciuniene J, Hartman T, et al. Comprehensive Gene Panel Testing for Hearing Loss in Children: Understanding Factors Influencing Diagnostic Yield. J Pediatr. 2023. PMID: 37473993. doi:10.1016/j.jpeds.2023.113620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。